Compare AstraZeneca plc (AZN) vs Rockwell Automation (ROK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Rockwell Automation — how do they compare? AstraZeneca plc trades at $157.99 (market cap $248.14B), while Rockwell Automation trades at $448.94 (market cap $49.64B). The key difference: AstraZeneca plc is far larger — about 5× Rockwell Automation's market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AZN | ROK | |
|---|---|---|
Market Cap | $248.14B | $49.64B |
Sector | Health | Industrials |
52-Week High | $209.48 | $495.08 |
52-Week Low | $147.06 | $333.75 |
Enterprise Value | $275.41B | $52.77B |
Dividend Yield | 2.01% | 1.23% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Rockwell Automation
Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.
Read more on ROK →
